Chongqing Pharscin Pharmaceutical Co., Ltd. (002907) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Chongqing Pharscin Pharmaceutical Co., Ltd.

Why is Chongqing Pharscin Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -3.30% and Operating profit at -20.21% over the last 5 years

Negative results in Mar 26

INTEREST(HY) At CNY 0.07 MM has Grown at 4,577.86%
NET PROFIT(HY) At CNY 24.73 MM has Grown at -33.77%
OPERATING CASH FLOW(Y) Lowest at CNY 71.49 MM

With ROE of 2.47%, it has a very expensive valuation with a 1.99 Price to Book Value

Over the past year, while the stock has generated a return of -18.80%, its profits have fallen by -40.2%
At the current price, the company has a high dividend yield of 0.6

Below par performance in long term as well as near term

Along with generating -18.80% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Chongqing Pharscin Pharmaceutical Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Chongqing Pharscin Pharmaceutical Co., Ltd.

-17.3%

0.03

30.46%

China Shanghai Composite

23.91%

1.73

13.79%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-3.30%

EBIT Growth (5y)

-20.21%

EBIT to Interest (avg)

23.95

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.32

Sales to Capital Employed (avg)

0.45

Tax Ratio

17.45%

Dividend Payout Ratio

48.11%

Pledged Shares

Institutional Holding

ROCE (avg)

7.58%

ROE (avg)

5.89%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.99

EV to EBIT

74.49

EV to EBITDA

27.08

EV to Capital Employed

2.48

EV to Sales

3.65

PEG Ratio

Dividend Yield

0.62%

ROCE (Latest)

3.33%

ROE (Latest)

2.47%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -7.88% (YoY

CASH AND EQV(HY)

Highest at CNY 1,232.59 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 2.84 times

PRE-TAX PROFIT(Q)

At CNY 37.03 MM has Grown at 89.4%

NET PROFIT(Q)

At CNY 32.35 MM has Grown at 102.37%

-14What is not working for the Company

INTEREST(HY)

At CNY 0.07 MM has Grown at 4,577.86%

NET PROFIT(HY)

At CNY 24.73 MM has Grown at -33.77%

OPERATING CASH FLOW(Y)

Lowest at CNY 71.49 MM

INTEREST COVERAGE RATIO(Q)

Lowest at 43,146.98

Here's what is working for Chongqing Pharscin Pharmaceutical Co., Ltd.

Pre-Tax Profit

At CNY 37.03 MM has Grown at 89.4%

over average net sales of the previous four periods of CNY 19.55 MM

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 32.35 MM has Grown at 102.37%

over average net sales of the previous four periods of CNY 15.99 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Cash and Eqv

Highest at CNY 1,232.59 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Inventory Turnover Ratio

Highest at 2.84 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by -7.88% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Chongqing Pharscin Pharmaceutical Co., Ltd.

Interest

At CNY 0.07 MM has Grown at 4,577.86%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 43,146.98

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Cash Flow

Lowest at CNY 71.49 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)